The ORC/Cdc6/MCM2-7 complex facilitates MCM2-7 dimerization during prereplicative complex formation. by Evrin, C et al.
The ORC/Cdc6/MCM2-7 complex facilitates
MCM2-7 dimerization during prereplicative
complex formation
Cecile Evrin1, Alejandra Ferna´ndez-Cid1, Alberto Riera1, Juergen Zech1, Pippa Clarke1,
M. Carmen Herrera1, Silvia Tognetti1, Rudi Lurz2 and Christian Speck1,*
1DNA Replication Group, MRC Clinical Sciences Centre, Imperial College, Du Cane Road, London W12 0NN,
UK and 2Microscopy Unit, Max Planck Institute for Molecular Genetics, Berlin 14195, Germany
Received February 1, 2013; Revised October 24, 2013; Accepted October 25, 2013
ABSTRACT
The replicative mini-chromosome-maintenance 2–7
(MCM2-7) helicase is loaded in Saccharomyces
cerevisiae and other eukaryotes as a head-to-head
double-hexamer around origin DNA. At first, ORC/
Cdc6 recruits with the help of Cdt1 a single
MCM2-7 hexamer to form an ‘initial’ ORC/Cdc6/
Cdt1/MCM2-7 complex. Then, on ATP hydrolysis
and Cdt1 release, the ‘initial’ complex is trans-
formed into an ORC/Cdc6/MCM2-7 (OCM)
complex. However, it remains unclear how the
OCM is subsequently converted into a MCM2-7
double-hexamer. Through analysis of MCM2-7
hexamer-interface mutants we discovered a
complex competent for MCM2-7 dimerization. We
demonstrate that these MCM2-7 mutants arrest
during prereplicative complex (pre-RC) assembly
after OCM formation, but before MCM2-7 double-
hexamer assembly. Remarkably, only the OCM
complex, but not the ‘initial’ ORC/Cdc6/Cdt1/
MCM2-7 complex, is competent for MCM2-7 dimer-
ization. The MCM2-7 dimer, in contrast to the
MCM2-7 double-hexamer, interacts with ORC/
Cdc6 and is salt-sensitive, classifying the arrested
complex as a helicase-loading intermediate.
Accordingly, we found that overexpression of the
mutants cause cell-cycle arrest and dominant
lethality. Our work identifies the OCM complex as
competent for MCM2-7 dimerization, reveals
MCM2-7 dimerization as a limiting step during
pre-RC formation and defines critical mechanisms
that explain how origins are licensed.
INTRODUCTION
DNA replication requires a robust replication
machinery to ensure faithful duplication of the genome
before cell division. To ensure that each part of the
genome is replicated only once, helicase loading and
helicase activation is separated into two phases (1).
During helicase loading, also known as DNA licensing,
the six subunit origin recognition complex (ORC), Cdc6
and Cdt1 facilitate the loading of the mini-chromosome-
maintenance 2–7 (MCM2-7) helicase onto DNA to form
the prereplicative complex (pre-RC) (2). MCM2-7, com-
posed of six highly related proteins, forms a hexamer in
solution but is loaded as a double-hexamer onto DNA
(3–5). The Mcm proteins form the core of the eukaryotic
replicative helicase (6,7), but the MCM2-7 complex is
inactive within the pre-RC (3,4). Helicase activation during
S-phase is triggered by a number of protein factors, cyclin
dependent kinase (CDK) and Dbf4 dependent kinase
(DDK) that target the MCM2-7 complex (1).
Pre-RC assembly is an ATPase-dependent process (1).
The pre-RC proteins Orc1-5, Cdc6 and Mcm2-7 belong to
the AAA+ family of ATPases (8,9). In Saccharomyces
cerevisiae, Orc1 and Cdc6 bind and hydrolyse ATP,
while Orc5 can only bind ATP and Orc2-4 have com-
pletely lost the ability to bind ATP (9,10). Work over
the past few years has shown that Cdc6 ATPase is
required for MCM2-7 loading, suggesting that Cdc6
ATPase is an integral part of the MCM2-7 loading mech-
anism (10,11). On the other hand, it was recently found
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that Orc1 ATP hydrolysis is also required for Cdt1 release
and MCM2-7 double-hexamer formation, indicating
that both Orc1 and Cdc6 work in a synergistic manner
(12). In contrast, the MCM2-7 ATPase activity is not
required for pre-RC formation in Xenopus cell-free
extracts and for in vitro pre-RC loading using puriﬁed
proteins, which is based on mutants in the Walker A
motif in Xenopus Mcm6, Mcm7 and the arginine ﬁnger
of S. cerevisiae Mcm3 (12,13). Recently it was shown
that in the absence of ATP hydrolysis an initial ORC/
Cdc6/Cdt1/MCM2-7 complex is formed on origin DNA.
This complex contains multiple Cdt1 molecules (14), but
only a single MCM2-7 hexamer (15). A cryo electron
microscopy structure of this complex has revealed the
overall architecture of the complex and identiﬁed that
the MCM2-7 C-termini interact with ORC/Cdc6 (16).
On ATP hydrolysis, Cdt1 is released from the initial
complex (10), resulting in an ORC/Cdc6/MCM2-7
(OCM) complex (12). However, the transition from
OCM to MCM2-7 double-hexamer is a slow process
(12). This indicates that origin recruitment of the second
hexamer is more complex and mechanistically distinct
from the recruitment of the ﬁrst hexamer.
How the OCM is transformed into the double-hexamer
is still elusive and so is the identity of many reaction inter-
mediates during pre-RC assembly. Is the OCM complex
proﬁcient to directly recruit a second hexamer
during initial MCM2-7 hexamer dimerization and what
are the structural requirements for successful MCM2-7
double-hexamer formation are unresolved questions.
Addressing these questions is necessary to uncover the
mechanism of regulated pre-RC assembly and cell
proliferation.
In this study, we investigated the process of MCM2-7
hexamer dimerization. We deﬁne MCM2-7 dimerization
as the state when the two MCM2-7 hexamers are bound
for the ﬁrst time to the replication origin, but have not yet
formed a salt stable double-hexamer. We show that a
series of MCM2-7 double-hexamer interface mutants
halt pre-RC formation at a late stage before double-
hexamer formation. In vivo these mutants lead to G1
arrest or slow entry into S-phase and cause dominant le-
thality. Furthermore, we observed that the MCM2-7
mutants assembled into an OCM complex in the
presence of ATP. Remarkably, the MCM2-7 interface
mutants, once integrated into the OCM complex, were
capable of MCM2-7 dimerization, but did not support
salt stable double-hexamer formation. Interestingly,
MCM2-7 dimerization is only occurring after ATP hy-
drolysis has occurred, highlighting that the OCM alone
and not the initial ORC/Cdc6/Cdt1/MCM2-7 complex is
able to form MCM2-7 dimers. These results suggest that
the MCM2-7 structure changes on ATP hydrolysis and
Cdt1 release to make the OCM competent for MCM2-7
dimerization. Furthermore, the data show that ORC/Cdc6
chaperones MCM2-7 before MCM2-7 double-hexamer
formation. In summary, our data demonstrate that
ORC/Cdc6 facilitates directly MCM2-7 dimerization and
show that productive MCM2-7 dimerization is essential
for pre-RC formation.
MATERIALS AND METHODS
In vitro pre-RC assembly assay
The pre-RCs were assembled in a one-step reaction: 40 nM
ORC, 80 nM Cdc6, 40 nM Cdt1, 40 nM MCM2-7 wt or
Ins mutants and 120 U Lambda phosphatase in buffer A
(50mM Hepes-KOH, pH 7.5, 100mM KGlu, 10mM
MgAc, 50 mM ZnAc, 3mM ATP, 5mM DTT, 0.1%
Triton and 5% Glycerol) plus 2mM MnCl2 were added
to 6 nM pUC19-ARS1 plasmid beads for 15min at 24C.
Beads were washed three times with buffer A plus 1mM
EDTA or buffer B (50mM Hepes-KOH, pH 7.5, 1mM
EDTA, 500mM NaCl, 5% Glycerol, 0.1% Triton and
5mM DTT) before digestion with 1U of DNaseI in
buffer A plus 5mM CaCl2 for 6min at 24
C.
Co-immunoprecipitation assays
Two standard size pre-RC reactions were prepared as
described above (in vitro pre-RC assembly assay),
released from DNA with AluI (New England Biolabs)
for 7.5min at 24C, pooled, immunoprecipitated with
anti-maltose binding protein (MBP) (New England
Biolabs) or anti-Mcm2 antibody coupled to protein G
beads for 7.5min at 24C, washed three times with
100 ml of buffer A and analyzed by western blot with
anti-Mcm2, anti-Cdt1, anti-Cdc6 (9H8/5, Abcam,
ab20150) and anti-Orc5.
RESULTS
Mutations in the MCM2-7 double-hexamer interface are
dominant lethal and cause a cell cycle arrest
MCM2-7 exists as a double-hexameric complex on DNA,
both in vivo and in vitro (3–5). However, it is currently
unclear how this complex is formed during pre-RC forma-
tion. To analyze the process, we generated a series of
mutants within the MCM2-7 double-hexamer interface,
which were designed to interfere with successful
MCM2-7 double-hexamer formation. Our mutational
approach is based on the crystal structure of an archaeal
N-terminal Methanobacterium thermoautotrophicum
MCM (mtMCM) (17) and a previous mutational
approach used to interfere with mtMCM double-
hexamer formation (18). The archaeal mtMCM and eu-
karyotic MCM2-7 are closely related in structure. In the
mtMCM structure, the interface between the two
hexamers spans a large surface and is localized within
the zinc binding domain of the MCM family (Figure
1A). Fletcher et al. introduced a six amino acid insertion
(6 Ins) between Cys-158 and Gly-159 of mtMCM,
encoding a ﬂexible GSGSGG sequence. mtMCM assem-
bles into a homo-hexamer, generating a complex contain-
ing six mutant subunits in each hexamer. The mutant
hexamer was not competent for double-hexamer forma-
tion in vitro, but had no inﬂuence on mtMCM hexamer-
structure, ATPase or DNA binding activity. Because the
S. cerevisiae MCM2-7 (scMCM2-7) complex is a hetero-
hexamer, it is possible to engineer mutant complexes con-
taining a scalable number of mutations from one to six.
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This strategy may allow the generation of mutant
complexes with intermediate phenotypes.
To generate scMCM2-7 mutants analogous to the
mtMCM 6ins mutants, we aligned mtMCM with
scMCM2-7 (Figure 1B). Consequently, we created 6ins
mutations in MCM2-7 by inserting the GSGSGG
peptide sequence after the conserved cysteine (Figure 1B)
in each of the six scMcm proteins (Ins MCM2-7) to
generate a series of Ins mutants, which we also refer to as
(double)-hexamer interface mutants, as the Ins site is
located at the predicted MCM2-7 double-hexamer inter-
face. As we predict that MCM2-7 double-hexamer forma-
tion is an important step during pre-RC formation, we set
out to test whether these Ins mutants exhibit a dominant
lethal phenotype in vivo (Figure 1C and D and
Supplementary Figure S1). The wild-type (wt) and
mutant mcm genes were co-expressed from 2-micron
plasmids using galactose-inducible promoters to
overexpress all six Mcm proteins. Overexpression was per-
formed in a yeast strain containing the wt chromosomal
copies of the MCM2-7 genes. Whenever a single Ins
mutant was overexpressed together with the ﬁve wt
Mcm proteins, we observed no effect (Supplementary
Figure S1A). The simultaneous overexpression of 2 Ins
mutants—especially the combination of Ins Mcm5 and
Ins Mcm7 with wt Mcm2, 3, 4 and 6 (5,7 Ins)—caused
some dominant lethality (Supplementary Figure S1B).
Co-overexpression of 3 (Figure 1C) or 4 Ins mutants
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Figure 1. Mutations in the MCM2-7 hexamer interface are dominant lethal. (A) Crystal structure of the N-termini of mtMCM assembled into a
double-hexamer (17). A conserved cysteine, which marks the site critical for hexamer interaction is shown in red. (B) Alignment of amino acids of the
N-terminal domain of scMCM2-7 and mtMCM involved in zinc binding and the hexamer interface. Two conserved cysteines are marked with red
arrows. A six amino acid loop (GGSGSG) was inserted after the second cysteine to speciﬁcally disturb the double-hexamer interface of MCM2-7.
MCM2-7 hexamer-interface mutants or combinations were overexpressed (galactose) from 2-micron plasmids in the (C) absence or (D) presence of
25mM HU to test for dominant lethal effects. In plates containing glucose the expression gets repressed. A strain containing vectors (pESC-Leu,
pESC-Trp and pESC-Ura) and a strain expressing wt MCM2-7 served as a control. All tested MCM strains contained, in addition to the mutants,
the complementing wt MCM genes so that always all six MCM2-7 genes were overexpressed. Serial dilutions of cells ranging from 1 107 to 1 103
were spotted on selective SC plates.
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(Supplementary Figure S1D) leads to a spectrum of pheno-
types: from poor growth to wt-like growth. Overexpression
of 5 or 6 Ins mutants showed a strong dominant-lethal
phenotype in all cases (Supplementary Figure S1E).
These results show that the effect of the mutants is additive,
suggesting that a partial disruption of the MCM2-7
double-hexamer interface is tolerated. Nevertheless, not
all strains expressing Ins mutant combinations showed
the same degree of dominant lethality, suggesting that
Mcm N-termini may have different roles during MCM2-
7 double-hexamer formation.
To investigate if any of the Ins mutants inﬂuence cell
viability during replication fork arrest, we challenged the
Ins mutants with hydroxyurea (HU) (Figure 1D and
Supplementary Figure S1). Overexpression of single Ins
mutants in combination with the ﬁve wt Mcm proteins
showed no HU-speciﬁc phenotype. This shows that no
single-mutant causes a speciﬁc defect during fork arrest,
and suggests that individual mutations do not compromise
S-phase–speciﬁc functions of MCM2-7. Also, some triple
mutants including 3,4,6 Ins and 4,5,6 Ins did not display
dominant lethality and were not sensitive to HU. A
number of mutants including 2,5,6 Ins and 3,6,7 Ins dis-
played near normal growth on overexpression, but were
sensitive to HU. In contrast, the overexpression of 4,5,7
Ins and 5,6,7 Ins and others caused dominant lethality,
which was further enhanced in the presence of HU. To
judge these results, one has to take into account that
multiple MCM2-7 double-hexamer complexes are loaded
at each origin, but only one double-hexamer per origin is
needed for DNA replication. The other MCM2-7 double-
hexamer copies have a backup role and become activated
in case a replication fork becomes blocked (19,20).
Therefore, mutants that reduce MCM2-7 loading, but
do not completely block pre-RC formation, should show
a growth reduction when challenged by HU
(Supplementary Figure S1), as these mutants do not
have sufﬁcient MCM2-7 complexes to generate new
forks after terminal fork stalling.
To address whether overexpression of triple mutants,
with a near normal (2,5,6 Ins) to intermediate growth
phenotype (4,5,7 Ins and 5,6,7 Ins), alters cell cycle pro-
gression, we arrested cells with nocodazole in G2 phase of
the cell cycle, induced MCM Ins mutant expression, then
released the cells and monitored cell cycle progression
using ﬂow cytometry (Figure 2A). All the Ins mutants
tested caused an arrest at the G1/S boundary or slow
G1-S transition with a near 1C DNA content
(Figure 2B, compare the 120-min time points). In
contrast, the corresponding strain overexpressing wt
MCM2-7 progressed normally through the cell cycle. It
is important to note that in the case of the 2,5,6 Ins
mutant we observed hardly any growth defect on solid
media, although we detected a cell cycle defect for the
same mutant in liquid culture. This could be
explained by the fact that galactose promoter-induced
expression is stronger for yeast grown in liquid media
than for yeast grown on solid media. Also, the overall
growth rate of cells on solid media is much lower than
the growth rate of yeast in liquid culture, giving yeast
growing in a petri dish more time to compensate for a
cell cycle defect.
In summary, we found that the triple mutants could be
grouped into four categories (Figure 2C) of phenotypes.
The ﬁrst category, which includes among others 2,5,7 Ins
and 3,5,7 Ins, displayed strong dominant lethality in the
absence and presence of HU. The second category, which
includes 4,5,7 Ins and 5,6,7 Ins, displayed dominant lethal-
ity on overexpression and this effect was further enhanced
by HU. The third category, including 2,5,6 Ins and 3,6,7
Ins, displayed near-normal growth on overexpression, but
dominant lethality in the presence of HU. Finally, the
fourth category, including 3,4,6 Ins and 4,5,6 Ins, did
not cause dominant lethality on overexpression and was
not sensitive to HU. Furthermore, this analysis indicates
that a mutation in Mcm7 more frequently causes a strong
growth defect, while mutations in Mcm4 and Mcm6 have
the least effect.
Based on this work, it is clear that Ins mutations can
cause a defect in cell cycle progression and viability. To
discover if these mutants have a speciﬁc pre-RC formation
defect, we used them in the following several in vitro assays.
MCM2-7 double-hexamer interface mutants are defective
in pre-RC assembly
Our in vitro analysis concentrated on triple mutants, as
these displayed a wide range of in vivo phenotypes with
some showing strong dominant lethality while others were
unaffected. We tested a number of triple mutants, two
from each category (Figure 2C, marked in bold), for
their ability to participate in pre-RC formation. Firstly,
we puriﬁed the Ins mutants using HA afﬁnity chromatog-
raphy and gel ﬁltration. The mutant proteins fractionated
during the gel-ﬁltration step similar to wt MCM2-7
(Supplementary Figure S2), besides one category 1
mutant (3,5,7 Ins) that displayed reduced hexamer stabil-
ity. These data show that most Ins mutants are capable of
forming a hexameric complex. Then we tested the mutants
in an in vitro pre-RC assay, which uses puriﬁed ORC,
Cdc6, Cdt1 and MCM2-7 proteins and origin DNA
linked to magnetic beads. We analyzed two category 2
MCM mutants (4,5,7 Ins and 5,6,7 Ins) (Figure 3A) and
found that these formed complexes with ORC/Cdc6 simi-
larly to wt MCM2-7 (Figure 3A, lanes 5–7). To identify
the presence of Cdt1 more clearly we performed also
western blots (Supplementary Figure S3). A high-salt
wash of pre-RC complexes removes DNA-associated
proteins like ORC, Cdc6 and Cdt1, but retains loaded
MCM2-7, as it encircles DNA as a double-hexameric
ring (3,4). As expected, we found that wt MCM2-7 was
loaded onto DNA, as it was retained on the DNA after a
high-salt wash (Figure 3A, lane 8). In contrast, the 4,5,7
Ins and 5,6,7 Ins MCM2-7 mutants failed to form a salt-
stable MCM2-7 complex with DNA (Figure 3A, lanes 9
and 10), suggesting that these MCM mutants were not
loaded onto DNA. Next we tested two mutants of
category 3 (2,5,6 Ins, 3,6,7 Ins) and 4 (3,4,6 Ins, 4,5,6
Ins) and one mutant of category 1 (3,5,7 Ins) in the
same assay. Most of the mutants associated with DNA
under low-salt buffer conditions similar to wt MCM2-7
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(Figure 3B, lanes 5–10). However, the category 1 (3,5,7
Ins) mutant, which exhibited reduced complex stability
during the puriﬁcation (Supplementary Figure S2),
associated less efﬁciently with ORC/Cdc6 than wt
MCM2-7 (Figure 3B, compare lane 5 and 10). For this
reason we excluded this mutant from other studies. The
category 4 mutants displayed some salt stable MCM2-7
loading (Figure 3B, compare lane 14 and 15 to lanes 11)
and the two category 3 mutants studied blocked the
loading of salt-stable MCM2-7 (Figure 3B, lanes 12 and
13). In summary, the mutants tested belonging to category
1, 2 and 3 blocked salt-stable MCM2-7 loading. On the
other hand, the two category 4 mutants affected MCM2-7
double-hexamer formation, but did not completely block
this process. This is consistent with our observation that
these mutants do not cause dominant lethality. Because
the category 4 mutants (3,4,6 Ins 4,5,6 Ins) did not
completely arrest pre-RC formation, we excluded these
mutants from other assays, as they could produce weak
or ambiguous phenotypes. Furthermore, these results
indicate that MCM2-7 with three mutated subunits can
retain some functionality. It is clear from these experi-
ments that all, but one, MCM2-7 double-hexamer inter-
face mutant tested associated well with ORC/Cdc6, and
that the category 2 and 3 Ins mutants failed to form a salt-
stable MCM2-7 complex onto DNA.
MCM2-7 hexamer interface mutants release Cdt1
efﬁciently during pre-RC formation
During pre-RC formation an ORC/Cdc6 complex assem-
bles on DNA, which then recruits Cdt1/MCM2-7 (21,22)
to form an initial ORC/Cdc6/Cdt1/MCM2-7 complex
(14,15). On ATP hydrolysis and Cdt1 release this
complex is transformed into the OCM (12). To test if
1
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the triple Ins mutants assemble into an initial ORC/Cdc6/
Cdt1/MCM2-7 complex and release Cdt1 (Figure 3 C) we
compared complex formation in the presence of ATPgS
and ATP with several Ins mutants belonging to categories
1–3. In the presence of ATPgS, which can be only slowly
hydrolysed, we observed efﬁcient binding of ORC, Cdc6,
Cdt1 and MCM2-7 to origin DNA both with wt and Ins
MCM2-7. In the presence of ATP we detected ORC, Cdc6
and MCM2-7, but Cdt1 was absent (Figure 3C, marked
with an asterisk). Reactions with ATP that were high-salt
washed showed salt-resistant MCM2-7 in the case of wt
MCM2-7, but not in the cases of category 1, 2 and 3 Ins
mutants. These data indicate that the Ins mutants form an
‘initial’ ORC/Cdc6/Cdt1/MCM2-7 complex in the
presence of ATPgS. Furthermore, we observed that all
Ins mutants tested released Cdt1 in the presence of ATP,
suggesting that these mutants are capable of OCM
complex formation.
Our in vitro analysis indicated that category 1 (2,5,7
Ins), 2 (4,5,7 Ins, 5,6,7 Ins) and 3 mutants (2,5,6 Ins and
3,6,7 Ins) associated efﬁciently with ORC/Cdc6, but failed
to produce salt-stable MCM2-7 loading. Out of the six
mutants that blocked MCM2-7 double-hexamer forma-
tion, the 2,5,6 Ins mutant caused the least dominant
lethal effect (Figures1 and 2C). As we were interested in
a mutant that blocks MCM2-7 loading, but besides this
causes minimal defects, our further in vitro work was
mostly focussed on the 2,5,6 Ins mutant.
The 2,5,6 Ins MCM2-7 hexamer interface mutant arrests
after OCM formation
The pre-RC assay suggested that 2,5,6 Ins and other
mutants were capable of releasing Cdt1 in an ATP hy-
drolysis–dependent manner. To corroborate these results
we determined the ability of the 2,5,6 Ins category 3
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Figure 3. MCM2-7 interface mutants block MCM2-7 loading. (A and B) pre-RC assays to test the ability of MCM2-7 hexamer-interface mutants to
associate with origin DNA in the presence of ATP, ORC, Cdc6 and Cdt1 and to load in a salt-stable way onto DNA. The hash symbol indicates the
presence of a nonspeciﬁc band that overlaps with the Cdt1 band. (C) Similar as A, but in lanes labeled ATPgS the ATP hydrolysis was blocked, to
verify the ability of the mutants to form an initial ORC/Cdc6/Cdt1/MCM2-7 complex. The asterisk marks the absence of Cdt1 in the sample
containing ATP, where ATP hydrolysis–dependent Cdt1 release and OCM formation is occurring. For all assays (A–C) a reconstituted system
containing puriﬁed 40 nM ORC, 80 nM Cdc6, 40 nM Cdt1, 40 nM MCM2-7 or 40 nM MCM2-7 mutants and origin containing 6 nM pUC19-ARS1
DNA coupled to magnetic beads was used to test the ability of the proteins to load the MCM2-7 helicase onto DNA. Experiments are shown with a
10% load (A and B) or a 30% load (C) of wt ORC, Cdc6, Cdt1 and MCM2-7. Experiments labeled with ‘low salt’ or ‘L’ tested wt MCM2-7 and
several mutant combinations for their ability to associate with origin containing DNA in the presence of ORC, Cdc6 and Cdt1. Experiments labeled
with ‘high salt’ or ‘H’ were performed in the same manner as low-salt experiments, but in the end were challenged with high salt, which removes
ORC, Cdc6, Cdt1 and in addition a fraction of the MCM2-7 helicase that was not loaded onto DNA.
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mutant to form ORC/Cdc6/Cdt1/MCM2-7 (Figure 4A)
and OCM (Figure 4B) complexes by immune precipitation
(IP) and in parallel we performed the same experiment
with wt MCM2-7. To measure ‘initial’ ORC/Cdc6/Cdt1/
MCM2-7 complex formation we assembled reactions in
the presence of ATPgS, washed the sample and then
released protein–DNA complexes from the magnetic
beads with a restriction enzyme. To avoid coprecipitation
of separate complexes, we used the AluI restriction
enzyme, which introduces 16 cuts into the plasmid of
2880 bp and excises an origin containing fragment of
237 bp. Then we immunoprecipitated 2,5,6 Ins MCM2-7
or wt MCM2-7 containing complexes with a Mcm2
antibody. The experiments were analyzed by quantitative
western blotting and a 2-fold dilution series of pre-RC
proteins is shown in Figure 4C. The IP showed efﬁcient
co-precipitating of Orc5, Cdc6, Cdt1 with Mcm2 for both
wt and 2,5,6 Ins MCM2-7 (Figure 4A, lanes 5 and 6). This
shows that the 2,5,6 Ins mutant forms an ‘initial’ ORC/
Cdc6/Cdt1/MCM2-7 complex in the presence of ATPgS in
a similar way to wt MCM2-7. However, with ATP we
observed for both wt and 2,5,6 Ins MCM2-7, Orc5 and
Cdc6 co-precipitation with Mcm2 (Figure 4B, lanes 5 and
6), but Cdt1 was absent. This shows that both 2,5,6 Ins
MCM2-7 and wt MCM2-7 form an OCM complex. In
summary, these data demonstrate that 2,5,6 Ins MCM2-
7 mutant can assemble into an ‘initial’ ORC/Cdc6/Cdt1/
MCM2-7 complex, which then matures on ATP hydroly-
sis and Cdt1 release into the OCM complex. To determine
whether the 2,5,6 Ins mutant does indeed promote ORC/
Cdc6 ATPase activity during OCM formation, we
measured ATP hydrolysis in the context of the pre-RC
assay (12).
We found that 2,5,6 Ins MCM2-7 on its own
hydrolyzed ATP at a similar level than wt MCM2-7
(Figure 4D, lanes 5 and 6). In context of Cdt1, the
ATP hydrolysis rate of 2,5,6 Ins MCM2-7 was reduced,
consistent with Cdt1/2,5,6 Ins MCM2-7 complex forma-
tion (Figure 4D, lane 9). Interestingly, wt MCM2-7/Cdt1
or 2,5,6 Ins MCM2-7/Cdt1 addition to ORC/Cdc6
increased the ATP hydrolysis rate signiﬁcantly (Figure
4D, lane 11 and 12), which is consistent with induction
of ATP hydrolysis during pre-RC formation (Figure 4D,
lanes 14 and 15) (12). We deﬁne the ‘pre-RC–induced
ATPase activity’ as the ATPase activity of the full pre-
RC reaction with the ATPase activities of the indi-
vidual components (ORC/Cdc6+Cdt1/MCM2-7) sub-
tracted (Figure 4D, marked in light gray). This
indicates that the 2,5,6 Ins mutant is inducing ATP
hydrolysis during pre-RC formation in a similar
fashion to wt MCM2-7.
To understand if a category 2 mutant behaved similarly,
we repeated the ATPase assay with 5,6,7 Ins (Figure 4D).
Interestingly, with this mutant on its own we observed
60% reduced ATPase activity. An ATP hydrolysis defect
in general should have no inﬂuence on pre-RC formation,
as MCM2-7 ATPase is not required for pre-RC formation
(12,13). However, it appears possible that the 5,6,7 Ins
mutant may have a conformational alteration, which
could impact on its function. We observed with the 5,6,7
Ins mutant a pre-RC–induced ATPase activity that was
A
T
P
 h
yd
ro
ly
si
s 
(p
m
ol
/m
in
) 18
16
14
12
10
8
6
4
2
0
1 2 3 4 5 6 7 8 9 10 11 12
pre-RC 
induced 
ATPase
activity
13 14 15 16
B
C
D
A
cat. 3
cat. 3
Figure 4. MCM2-7 hexamer interface mutants arrest during pre-RC
formation in complex with ORC/Cdc6. (A) Pre-RC complexes with
wt MCM2-7 and 2,5,6 Ins MCM2-7 were formed in the presence of
ATP and ATPgS (B) and released from magnetic beads via restriction
endonuclease digest. Complexes were immunoprecipitated with
anti-Mcm2 antibodies, analyzed by western blot and compared with
a 2-fold dilution series of pre-RC proteins and a control IP (C). (D)
Analysis of ATPase activities during pre-RC assembly with wt
MCM2-7, 2,5,6 Ins MCM2-7 and 5,6,7 Ins MCM2-7. The ATP
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reduced by 25% in comparison with the wt. This reduction
could result in slower OCM formation, but is not blocking
Cdt1 release in general (Figure 3A and 3C). Nevertheless,
it is clear that the 5,6,7 Ins category 2 mutant has a con-
formational alteration, which leads to reduced MCM2-7
and pre-RC–induced ATP hydrolysis. On the other hand,
we demonstrate that the 2,5,6 Ins category 3 mutant is
able to assemble into an ‘initial’ ORC/Cdc6/Cdt1/
MCM2-7 complex, to facilitate normal pre-RC–induced
ATP hydrolysis, to release Cdt1 and to form an OCM
complex.
The transition from MCM2-7 dimer to double-hexamer
makes the helicase competent for efﬁcient DDK
phosphorylation
Our data show some triple mutants–displayed defects in
OCM formation. On the other hand, the 2,5,6 Ins mutant
appeared capable of normal ATP hydrolysis–driven Cdt1
release, suggesting that this mutant could function
for processes after OCM complex formation (Figures 3
and 4). MCM2-7, within the OCM, might adopt a struc-
ture similar to the double-hexamer. To address this
question, we used DDK kinase (Cdc7-Dbf4) as a struc-
tural sensor, as DDK has been shown to preferentially
phosphorylate MCM2-7 within the double-hexamer and
less efﬁciently if pre-RC assembly is blocked by a Cdc6
E224G ATP hydrolysis mutant (23,24). Consistent with
previous work, we found that puriﬁed MCM2-7 in the
absence of other proteins is weakly phosphorylated
by DDK on Mcm2, Mcm4 and Mcm6 (Figure 5A, lane
8). Interestingly, the puriﬁed Ins mutants were
phosphorylated by DDK in an identical manner to wt
MCM2-7 (Supplementary Figure S4). This result indicates
that the 6 Ins mutations did not result in a change of the
MCM2-7 complex that leads to altered phosphorylation.
To evaluate if the Ins containing OCM is targeted by
DDK in a similar manner than the MCM2-7 double-
hexamer we prepared pre-RC reactions with wt MCM2-
7 and several Ins mutants. After complex formation,
DDK and P32-ATP were added and then the reactions
were split and analyzed for MCM2-7 protein content
(Supplementary Figure S5) and for DDK-dependent
phosphorylation of Mcm and other proteins (Figure 5B
and C). After correcting for differences in protein amounts
(Supplementary Figure S5) we plotted the DDK-depend-
ent phosphorylation of wt MCM2-7 and the Ins mutants
in Figure 5D. The data show robust phosphorylation of
loaded MCM2-7 and reduced phosphorylation in the
presence of Cdc6 E224G, which partially blocks pre-RC
assembly. With the Ins mutants we also observed reduced
phosphorylation of Mcm2, Mcm4 and Mcm6 (Figure 5B
and D). These results indicate that Ins MCM2-7 mutants,
when integrated in the OCM, are not an optimal substrate
for phosphorylation by DDK, similar as with Cdc6
E224G. Another possibility could be that the Ins
mutants are differentially pre-phosphorylated, which
could affect their ability to be phosphorylated by DDK
(23). Although this is possible, we think that it is unlikely,
as DDK phosphorylated puriﬁed wt and mutant MCM2-7
in an identical fashion.
The OCM complex is competent for MCM2-7
dimerization
Currently it is unclear how the OCM is transformed into
the MCM2-7 double-hexamer. One possibility is that the
OCM itself functions as a platform for the double-
hexamer (12). If that is the case, then a salt unstable
MCM2-7 dimer could be formed before establishment of
an MCM2-7 double-hexamer; however, such an MCM2-7
dimer has never been observed. Interestingly, the 2,5,6 Ins
mutant supports normal OCM formation, but is unable to
form a salt-stable MCM2-7 double-hexamer. Therefore
we set out to investigate if the OCM formed with 2,5,6
Ins is competent to establish an MCM2-7 dimer.
To measure dimerization, we used a co-immunopre-
cipitation approach using a mixture of MBP-tagged wt
MCM2-7 with untagged 2,5,6 Ins MCM2-7 (category 3).
Complexes were formed on DNA, released via restriction
digest and immunoprecipitated with an anti-MBP
antibody (Figure 6A). In our in vitro system 1–1.5
MCM2-7 molecules bind on average to each DNA
molecule, indicating that each DNA plasmid could be in
complex with more than one MCM2-7 hexamer. To
hinder the coprecipitation of two independent OCM
complexes, we cut the plasmid with the AluI restriction
enzyme at 16 places and generating an origin containing
fragment of 237 bp. Importantly, we performed the
experiment in the presence of ATPgS as well to control
for nonspeciﬁc dimerization, as in the presence of ATPgS
only a single MCM2-7 hexamer is recruited to ORC/Cdc6
and Cdt1 (15). In the presence of ATPgS, we observed
only negligible amounts of untagged Mcm2 in the anti-
MBP pull-down (Figure 6B, lane 8), but efﬁcient co-
precipitation of Orc5, Cdc6 and Cdt1 with MBP-Mcm2.
Remarkably, in the presence of ATP we observed robust
co-immunoprecipitation of untagged MCM2-7 in the
MBP-pulldown (Figure 6C, lane 8). Furthermore, this
complex contained Cdc6 and Orc5, but Cdt1 was absent.
To verify that MCM2-7 dimer is not involving two inde-
pendent complexes held together by DNA, we repeated the
experiment, but released the complexes by DNase I from
the magnetic beads. We observed a similar dimer as with
the Alu I restrictions digest (Supplementary Figure S6A).
Importantly, the observed dimer does not represent a
MCM2-7 double-hexamer, as wt MCM2-7 does not facili-
tate the loading of the 2,5,6 InsMCM2-7 mutant into a salt
stable MCM2-7 double-hexamer (Supplementary Figure
S6C). Furthermore, MBP-MCM2-7 loads efﬁciently onto
DNA (Supplementary Figure S6B and C). This experiment
shows that a 2,5,6 Ins containing OCM complex is
competent for MCM2-7 dimerization, whereas the initial
Figure 4. Continued
hydrolysis rates were determined for the indicated proteins in the
presence of ARS1 origin DNA. Together ORC, Cdc6, Cdt1 and
MCM2-7 induced a strong ATPase activity. Lanes 14–16 show only
the pre-RC–induced ATPase activity [ATPase activity of the full pre-
RC reaction with the ATPase activity of the individual components
(ORC/Cdc6+Cdt1/MCM2-7) subtracted].
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ORC/Cdc6/Cdt1/MCM2-7 did not facilitate dimer
formation.
To corroborate this result, we wanted to visualize such a
dimer containing complex by electron microscopy using
category 2 and 3 mutants. We studied metal shadowed
pre-RC complexes containing Ins MCM2-7 and included
ORC/Cdc6 (Figure 6D), wt MCM2-7 double-hexamer
(Figure 6E) and a pre-RC arrested with ATPgS
(Figure 6F) as controls. The pre-RC formed in the
presence of ATPgS is a good reference, as it contains
only a single MCM2-7 hexamer in complex with ORC/
Cdc6 and Cdt1 (15). Interestingly, 2,5,6 Ins and 4,5,7
Ins MCM2-7 assembled in the presence of ATP in two
species of complexes (Figure 6G and H). We observed a
small Ins MCM2-7 containing complex (Figure 6F and G;
upper part), which was similar to the pre-RC ATPgS
complex. In addition, we observed a large Ins MCM2-7
containing complex (Figure 6F and G; lower part), which
appeared bigger than the MCM2-7 double-hexamer, sug-
gesting that this complex contains an MCM2-7 dimer in
complex with ORC/Cdc6. Furthermore, we found that the
small 2,5,6 Ins complex (77 out of 107 molecules, 71%)
was more abundant than the large 2,5,6 Ins complex (30
out of 107 molecules, 28%). This is reminiscent of our
ﬁnding that only some of the 2,5,6 Ins containing OCM
complex was competent for dimerization. These electron
microscopy data are consistent with the co-immunopre-
cipitation experiments and suggest that 2,5,6 Ins and
4,5,7 Ins can assemble into large MCM2-7 dimers in
complex with ORC/Cdc6.
DISCUSSION
Here we report that 2,5,6 Ins MCM2-7 can form an OCM
complex in an ATP hydrolysis–dependent manner.
Remarkably, this 2,5,6 Ins MCM2-7 containing OCM
complex is competent for the initial recruitment of a
second MCM2-7 hexamer and thus promotes MCM2-7
dimerization. However, the Ins mutants cannot form a
MCM2-7 double-hexamer and MCM2-7 dimerization is
not occurring in the absence of ATP hydrolysis. The
MCM2-7 dimer, in contrast to the MCM2-7 double-
hexamer, is a late pre-RC intermediate as it is found in
complex with ORC/Cdc6 and is salt sensitive. These
results suggest that ATPase-dependent OCM formation
makes MCM2-7 competent for dimerization and that
the 2,5,6 Ins mutation blocks the formation of a stable
double-hexamer interface.
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Figure 5. Double-hexamer formation triggers a structural change in MCM2-7. DDK-mediated phosphorylation of individual pre-RC proteins (lanes
1–8) or DNA-bound pre-RC complexes (lanes 9–20). The upper panel shows silver stained gels and the lower panel the autoradiogram of the same
gel. Forty nanomolar ORC, Cdc6, Cdt1 and wild-type MCM2-7 were individually incubated for 15min at 27C either in the absence (lanes 1–4) or in
the presence of 40 nM DDK and g32P-ATP (lanes 5–8). The pre-RC assembly was performed with 6 nM pUC19-ARS1, 40 nM ORC, 80 nM Cdc6
wild-type or Cdc6 E224G, 40 nM Cdt1 and 40 nM wild-type MCM2-7 or 40 nM Ins MCM2-7 mutants (lanes 14-–20). A 10% load of the
unphosphorylated proteins and DDK is shown in lanes 9–13. The pre-RC was formed with wild-type pre-RC proteins (lane 14), a Cdc6 ATP
hydrolysis mutant E224G (lane 15) and ﬁve different Ins MCM mutants (lane 16–20).
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Figure 6. MCM2-7 hexamer-interface mutants promote ATP hydrolysis–dependent MCM2-7 dimerization. (A) Experimental outline for (B and C).
Pre-RC assays were assembled in the presence of ATPgS and ATP. When tagged and untagged MCM2-7 were used, equimolar amounts of each
complex were combined in pre-RC reactions. Complexes were released from DNA via restriction digest and DNA-bound complexes were
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anti-Orc5 antibodies. (B) In the presence of ATPgS MCM2-7, dimerization is absent. The experiment was performed as described in (A). (C) MCM2-
7 dimerization is facilitated by ATP hydrolysis. The experiment was performed as described in (B), except that ATP was used. (D) ORC/Cdc6,
(E) MCM2-7 double-hexamer, (F) pre-RC ATPgS (G) 2,5,6 Ins MCM2-7 or (H) 4,5,7 Ins MCM2-7 were assembled on DNA, gel-ﬁltered, ﬁxed with
glutaraldehyde and visualized by rotary shadowing with platinum. Magniﬁcation of individual complexes is shown to indicate the differences in size
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The MCM2-7 hexamer interface mutation causes a late
arrest in pre-RC formation
We have used MCM2-7 interface mutants to understand
the mechanism of double-hexamer formation. The speciﬁc
mutations were designed based on structural information
of a close homologue, an archaeal mtMCM, and are
localized toward the N-terminal tip of the protein
complex. The same mutation in three scMCM subunits
did not affect the puriﬁcation characteristics of six
category 2–4 Ins MCM2-7 mutants, the hexameric struc-
ture of these Ins MCM2-7 complexes as judged by gel
ﬁltration, the ability of most of the mutants to interact
with ORC/Cdc6/Cdt1 or the DDK phosphorylation
patterns of MCM2-7. Furthermore, we speciﬁcally found
that the 2,5,6 Ins mutant assembles into an OCM complex
and promotes pre-RC–induced ATP hydrolysis similar to
wt MCM2-7. Based on these results, it is unlikely that the
2,5,6 Ins mutant has a large overall conformational
alteration. Consistent with that, the 2,5,6 Ins MCM2-7
interface mutant is capable of MCM2-7 dimerization,
but fails to form a salt-stable MCM2-7 double-hexamer.
Within the ORC/Cdc6/Cdt1/MCM2-7 complex, ORC/
Cdc6 interacts with the MCM2-7 C-termini (16), which
leaves the MCM2-7 N-termini available for interaction.
Thus the OCM recruits most likely the second MCM2-7
hexamer via an interaction involving the N-terminal
hexamer interface. In case of the 2,5,6 Ins mutant, we
predict that the partial contacts between the two
MCM2-7 hexamers are strong enough to support recruit-
ment of the second hexamer (dimerization), but not strong
enough to allow salt-stable double-hexamer formation.
On the other hand, it has been suggested that the second
MCM2-7 could also be recruited via ORC/Cdc6 (14);
however, the cryo-electron microscopy structure of the
ORC/Cdc6/Cdt1/MCM2-7 did not identify a second
ORC/Cdc6–MCM2-7 interaction site (16). Therefore we
propose that initial hexamer dimerization occurs via the
N-terminal hexamer interface that is followed by a struc-
tural change, which could involve a locking mechanism
that facilitates the formation of a tight interaction
between each MCM2-7 hexamer. The 2,5,6 Ins hexamer-
interface mutant could block this process speciﬁcally, but
we can not exclude the possibility that a different
structural change within the N-terminal section could
prevent stable double-hexamer formation. Another inter-
esting possibility is that double-hexamer formation is
coordinated with MCM2-7 ring opening, which may
require orchestrated interactions between both hexamers.
Furthermore, other mutants may have additional
defects, for example, 3,5,7 Ins blocks the association
with ORC/Cdc6 (Figure 3B). One possibility is that the
Ins mutation could alter the inter-subunit interactions,
which could explain the ATP hydrolysis defect seen in
5,6,7 Ins.
Moreover, the MCM2-7 double-hexamer does not bind
ORC/Cdc6 (15), but we observed that the MCM2-7 dimer
maintains association with ORC/Cdc6, suggesting that
successful MCM2-7 double-hexamer formation triggers
another structural change in MCM2-7, resulting in
ORC/Cdc6 release.
Requirements for productive MCM2-7 dimerization
Previous work has shown that the binding of Cdt1/
MCM2-7 to ORC/Cdc6 yields an initial ORC/Cdc6/
Cdt1/MCM2-7 complex (14–16). In the absence of ATP
hydrolysis no MCM2-7 dimerization occurs (15).
Furthermore, Cdc6 and Orc1 ATP hydrolysis promotes
the release of Cdt1 and yields an OCM complex.
Consistent with that we found no dimerization of the
2,5,6 Ins category 3 MCM2-7 hexamer interface mutant
in the presence of ATPgS. On the other hand, we detected
dimerization with the same mutant in the presence of
ATP using a co-immunoprecipitation assay, and we
also observed complexes that appeared larger than the
MCM2-7 double-hexamer by electron microscopy.
Importantly, MCM2-7 does not form dimers in solution,
showing that ORC/Cdc6 induces a dimerization compe-
tent state. Interestingly, the percentage of MCM2-7 dimer
formation (27.6%) (Figure 6C) and MCM2-7 loading into
double-hexamers (15–30%) (3) is similar. These data
suggest that the MCM2-7 dimer is a precursor of the
MCM2-7 double-hexamer. Moreover, the MCM2-7
dimer could represent a limiting step during pre-RC for-
mation, since the majority of MCM2-7 molecules formed
OCM complexes, but only some formed MCM2-7 dimers
and double-hexamers.
In summary, our data show two requirements for initial
MCM2-7 dimerization and dimer function during double-
hexamer formation. The ﬁrst requirement is OCM forma-
tion, as dimer establishment requires MCM2-7 to be in
complex with ORC/Cdc6, e.g. MCM2-7 on its own or
when integrated within the initial ORC/Cdc6/Cdt1/
MCM2-7 complex does not form a dimer. The second
requirement is the establishment of a tight MCM2-7
hexamer–hexamer interface, as Ins mutations do not
block dimerization, but fail to form a double-hexamer.
Based on previous work (12) and this work, it is clear
that ORC/Cdc6 maintains interaction with MCM2-7 after
OCM formation. This indicates that pre-RC formation
does not involve an uncomplexed single-hexamer
intermediate or MCM2-7 dimer and we suggest
that ORC/Cdc6 chaperones MCM2-7 hexamer before
double-hexamer formation. The function of ORC/Cdc6
is likely to stabilize MCM2-7 on DNA and to hinder the
loading of uncomplexed single-hexameric onto DNA.
Importantly, our data suggest that OCM-induced
MCM2-7 dimerization promotes stable MCM2-7
double-hexamer formation.
In the future, it will be important to determine (i) if one
or two ORC/Cdc6 complexes participate in dimerization;
(ii) if DNA sequence inﬂuences dimerization and (iii) to
understand the structure of the dimeric MCM2-7
complex.
An unequal role of the Mcm2-7 N-termini in
double-hexamer formation
We have analyzed all combinations of three mutant mcm
genes with three wt MCM genes for dominant lethal
phenotypes and observed reduced growth with several
mutants when compared with the overexpression of wt
MCM2-7. Furthermore, for 2,5,6 Ins, 4,5,7 Ins and 5,6,7
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Ins, we detected a cell cycle defect. This indicates that the
Ins mutation interferes with an important function. Our
in vitro analysis suggests that the 2,5,6 Ins mutant still
maintains the capability for initial MCM2-7 dimerization,
while this mutant fails to form the salt-stable MCM2-7
double-hexamer. This suggests that MCM2-7 double-
hexamer formation is an essential process in vivo. When
we compared the growth phenotype of the mutant com-
binations we found that the introduction of the Ins muta-
tions in mcm4 and mcm6 affects growth weakly, but
mutant combinations containing the Ins-mcm7 mutation
were more strongly affected. This could be due in part to a
structural change, as the Ins-mcm7 containing 3,5,7 Ins
mutant displayed reduced stability during the puriﬁcation
and weak binding to ORC/Cdc6. However, other mutants
containing Ins-mcm7 including 3,6,7 Ins and 4,5,7 Ins
puriﬁed normal and allowed efﬁcient OCM formation.
This suggests that the structural context has an inﬂuence
on complex stability—the speciﬁc mutant combination is
more important than the inﬂuence of the single mutation.
Moreover, the analysis of the mutants highlighted four
different categories of mutants (Figure 2C). The mutants
in category 4 were capable of some salt-stable MCM2-7
loading, explaining why these mutants displayed no
dominant lethality. On the other hand, the category 1–3
mutants were not able to load salt-stable MCM2-7 onto
DNA, but had various in vivo and in vitro deﬁciencies. The
category 1 mutants, in particular, displayed several defects
including reduced hexamer stability (3,5,7 Ins), weak
association with ORC/Cdc6 (3,5,7 Ins) and poor phos-
phorylation by DDK (2,5,7 Ins) and were causing strong
dominant lethality. The category 2 mutants were capable
of OCM formation (4,5,7 Ins and 5,6,7 Ins), but showed
reduced pre-RC–induced ATPase activity (5,6,7 Ins) and
caused dominant lethality on overexpression. Finally, the
category 3 mutants and in particular 2,5,6 Ins was
functional for OCM formation, displayed normal pre-
RC–induced ATPase activity and was capable of
MCM2-7 dimerization, but failed to form a stable
double hexamer. It is interesting to note that the
category 3 mutants (2,5,6 Ins and 3,6,7 Ins) showed
near-normal growth on overexpression, but revealed
dominant lethality on addition of HU. Based on our
in vitro analysis it is likely that overexpression of these
mutants causes a MCM2-7 loading defect in vivo.
However, this effect is not sufﬁcient to completely block
DNA replication, as MCM2-7 loading is a highly redun-
dant process, and hence we observed cell growth.
Interestingly, reduced MCM2-7 loading in the human or
Xenopus system renders cells sensitive to HU, as these cells
lack sufﬁcient MCM2-7 complexes for reactivation after a
terminal fork arrest. It is tempting to speculate that
reduced MCM2-7 loading due to the Ins mutation
rendered the cells sensitive to HU and fork arrest.
A model for ORC/Cdc6-mediated MCM2-7
dimerization and helicase loading
Based on the coordinated and distinct structural changes
in MCM2-7, which are promoted by ORC and its
cofactors Cdc6 and Cdt1, we propose a model that
explains how the MCM2-7 double-hexamer loading onto
DNA occurs (Figure 7). ORC binds in an ATP-dependent
way to the replication origin (25) (Figure 7A). In G1
phase, Cdc6 is recruited to ORC in an ATP-dependent
fashion (9,26–29) (Figure 7B). Cdt1 forms a complex
with MCM2-7 and this interaction is required for the
initial recruitment of MCM2-7 to ORC/Cdc6
(3,4,12,14,22). Initially only one MCM2-7 hexamer is re-
cruited to ORC/Cdc6 (15). In the absence of Cdc6 ATP
hydrolysis, Cdt1 is greatly stabilized in this ‘initial’ ORC/
Cdc6/Cdt1/MCM2-7 complex (31) (Figure 7C). Rapid
ATP hydrolysis results in Cdt1 release and formation of
an OCM complex (12) (Figure 7D). The OCM complex,
but not the ‘initial’ complex, is competent for MCM2-7
dimerization (Figure 7E). Currently, it is not clear if one
or two ORC/Cdc6 complexes participate in MCM2-7 di-
merization or when DNA loading occurs. After initial
dimerization, several important changes occur: the
MCM2-7 N-termini are exposed, rendering the complex
competent for DDK-mediated activation in S-phase, the
stable MCM2-7 double-hexamer forms around ds-DNA,
ORC and Cdc6 are released, and ﬁnally Orc1 ATP
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Figure 7. A model for ORC/Cdc6 mediated MCM2-7 dimerization and
helicase loading. A model of the MCM2-7 loading process is shown.
(A) ORC is bound to DNA. (B) Cdc6 associates with ORC. (C) Cdt1/
MCM2-7 associates with ORC/Cdc6. (D) ATP hydrolysis leads to Cdt1
release and OCM formation. (E) OCM formation results in a structural
change in MCM2-7 to generate a dimerization competent state of the
MCM2-7 helicase and recruitment of a second MCM2-7 complex. The
recruitment of the second complex may require another ORC/Cdc6
complex. (F) The MCM2-7 loading ﬁnishes with the formation of a
stable double-hexamer encircling DNA, which leads to exposure of the
Mcm2, 4 and 6 N-termini. ORC ATP hydrolysis is required for
repetitive MCM2-7 loading.
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hydrolysis occurs to allow another round of MCM2-7
loading (Figure 7F).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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